Flunixin is a non-steroidal anti-inflammatory
drug (NSAID), and a non-narcotic analgesic with
antipyretic properties.
-
Flunixin (as meglumine)
50
mg.
-
Excipients ad.
1
ml.
Description
Flunixin is a non-steroidal anti-inflammatory
drug (NSAID), and a non-narcotic analgesic with
antipyretic properties. It is used in the alleviation of
inflammation and pain associated with musculoskeletal
disorders and colic. In addition it is used
for the control of acute inflammation reactions
associated with infectious diseases. Flunixin is
also applied as adjunctive therapy in the treatment
of respiratory diseases.
Indications
Cattle: Banixin-50 is indicated for the control of
pyrexia associated with bovine respiratory disease,
endotoxemia and acute bovine mastitis. Banixin-50
is also indicated for the control of inflammation in
endotoxemia and as an adjunct to antimicrobial
therapy to reduce clinical signs of acute
inflammation in cases of infectious respiratory
disease.
Horses: Banixin-50 is indicated for the alleviation
of inflammatory signs associated with musculoskeletal
disorders and for the alleviation of visceral
pain associated with colic.
Swine: Banixin-50 is indicated as an adjunctive
therapy in the treatment of swine respiratory
diseases.
Contra indications
Do not exceed the recommended dose or duration
of treatment.
Do not use in horses used in competitive sports.
Do not administer to pregnant mares or sows,
or 48 hours before expected parturition until
postpartum expulsion of the placenta in cows.
Do not use in lactating mares producing milk for
human consumption.
Do not use in bulls intended for breeding, as
reproductive effects of Banixin-50 in these classes
of cattle have not been investigated.
Do not administer to dehydrated, hypovolaemic
or hypotensive animals or animals suffering from
cardiac, hepatic or renal disease.
Banixin-50 is contraindicated in animals with
risk of gastro-intestinal ulceration or bleeding,
where there is evidence of a blood dyscrasia or
hypersensitivity to the product.
Do not administer to animals undergoing general
anaesthesia until fully recovered.
Avoid intra-arterial injection or concurrent
administration of other NSAIDs and nephrotoxic
drugs.
Use in any animal less than 6 weeks of age or in
aged animals may involve additional risks.
Side effects
Adverse reactions include gastro-intestinal
irritation, ulceration, changes in haematology
and, in dehydrated, hypovolaemic or hypotensive
animals, a potential for renal damage.
In rare cases, severe analphylactoid reactions
have been observed, occasionally with fatal
outcome.
Dosage
For intramuscular or intravenous administration.
Cattle:
2 ml per 45 kg bodyweight. Repeat if necessary at
24 h intervals for up to 3 consecutive days.
Swine:
2 ml per 45 kg bodyweight once by intramuscular
injection only.
Horses:
1 ml per 45 kg body weight by intravenous
injection only. Treatment may be repeated once or
twice if colic recurs. In case of musculo-skeletal
disorders, treatment is once daily for up to 5 days
according to clinical response.
Inject the product slowly, and apply at body
temperature. Administration should be stopped
immediately if signs of intolerance occur. An
adequate water supply should be provided.
Withdrawal times
- For meat:
Cattle : 14 days.
Pigs : 24 days.
- For milk:
Cattle : 2 days.
Do not use in horses producing meat or milk for
human consumption.
